Membrane Hyperpolarization in Hypoxic Vasorelaxation

  • G. Siegel
  • J. Grote
Conference paper

Abstract

Shortly after the discovery of endothelium-dependent relaxation of smooth muscle cells in blood vessels (1) it became apparent that endothelial cells also could generate vasoconstrictor signals (2). Both endothelium-dependent relaxation and contraction can be attributed to the release of vasoactive substances from the intimal cells that have been designated as an endothelium-dependent relaxing factor (EDRF) and endothelium-dependent contracting factor or EDCF (3). There is increasing evidence that endothelial cells can intervene in peripheral vascular regulation besides numerous other effector influences by balancing the production of EDRFs and EDCFs. It is known that in atherosclerosis, cerebral and coronary vasospasm, and hypertension, endothelial cells either lose their ability to produce EDRF or this substance is no longer able to control vascular tone. But the ability to secrete EDCF appears unperturbed or even augmented (4). Thus, the rationale for undertaking the present research should be considered within this context, namely, to estimate the role of these substances in local vascular control under physiological conditions and to analyze their interaction with the already known effectors. Thus, it can be demonstrated that not only endothelial cells but also smooth muscle cells possess peripheral chemoreceptors sensitive to changes in Po2.

Keywords

Platinum Prostaglandin Noradrenaline Acetylcholine Indomethacin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Furchgott RF, Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376.PubMedCrossRefGoogle Scholar
  2. 2.
    Rubanyi GM, Vanhoutte PM (1985). Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol (Lond) 364: 45–56.Google Scholar
  3. 3.
    Vanhoutte PM (1987). Endothelium and the control of vascular tissue. News Physiol Sci 2: 18–22.Google Scholar
  4. 4.
    Löscher TF (Ed). (1988). Endothelial Vasoactive Substances and Cardiovascular Disease, Basel: S Karger.Google Scholar
  5. 5.
    Siegel G, Walter A, Thiel M, Ebeling BJ (1984). Local regulation of blood flow. Adv Exp Med Biol 169: 515–540.PubMedGoogle Scholar
  6. 6.
    Grote J, Siegel G, Adler A, Zimmer K, Müller R (1987). The effect of hypoxia on the electro-mechanical properties of the canine carotid artery. In: CervósNavarro J, Ferszt R (Eds). Stroke and Microcirculation, New York: Raven Press, pp. 51–56.Google Scholar
  7. 7.
    Siegel G, Schnalke F, Grote J, Stock G (1988). Membrane physiological mechanisms of vasorelaxation. In: Halpern W, Pegram BL, Brayden JE, Mackey K, McLaughlin MK, Osol G (Eds). Resistance Arteries, Ithaca: Perinatology Press, pp. 170–178.Google Scholar
  8. 8.
    Siegel G, Grote J, Schnalke F, Zimmer K (1989). The significance of the endothelium for hypoxic vasodilatation. Z Kardiol 78 (Suppl 6): 124–131.PubMedGoogle Scholar
  9. 9.
    Busija DW (1984). Sympathetic nerves reduce cerebral blood flow during hypoxia in awake rabbits. Am J Physiol 247: H446 - H451.PubMedGoogle Scholar
  10. 10.
    Sylvester JT, Scharf SM, Gilbert RD, Fitzgerald RS, Traystman RJ (1979). Hypoxic and CO hypoxia in dogs: hemodynamics, carotid reflexes, and catecholamines. Am J Physiol 236: H22 - H28.PubMedGoogle Scholar
  11. 11.
    Aprigliano O, Hermsmeyer K (1976). In vitro denervation of the portal vein and caudal artery of the rat. J Pharmacol Exp Ther 198: 568–577.PubMedGoogle Scholar
  12. 12.
    Palmer RMJ, Ferrige AG, Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526.PubMedCrossRefGoogle Scholar
  13. 13.
    Siegel G, Grote J (1988). Poz induced changes of membrane potential and tension in vascular smooth musculature. In: Acker H (Ed). Oxygen Sensing in Tissues, Berlin: Springer-Verlag, pp. 131–142.Google Scholar
  14. 14.
    Siegel G, Schnalke F, Stock G, Grote J (1989). Prostacyclin, endothelium-derived relaxing factor and vasodilatation. Adv Prostaglandin Thromboxane Leukotriene Res 19: 267–270.Google Scholar
  15. 15.
    Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415.PubMedCrossRefGoogle Scholar
  16. 16.
    Siegel G, Bostanjoglo M, Thiel M, Adler A, Carl A, Stock G, Grote J (1987). Membranphysiologische Mechanismen der Vasodilatation. In: Betz E (Ed). Frühveränderungen bei der Atherogenese, München: W Zuckschwerdt Verlag, pp. 91–101.Google Scholar
  17. 17.
    Siegel G, Mironneau J, Schnalke F, Loirand G, Stock G (1990). Effect of the K+ channel opener iloprost on membrane potential, tension and transmembrane ion exchange in vascular smooth muscle. J Pharmacol Exp Ther (in press).Google Scholar
  18. 18.
    Feletou M, Vanhoutte PM (1988) Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 93: 515–524.PubMedGoogle Scholar
  19. 19.
    Huang AH, Busse R, Bassenge E (1988). Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide). Naunyn-Schmiedeberg’s Arch Pharmacol 338: 438–442.PubMedGoogle Scholar
  20. 20.
    Taylor SG, Weston AH (1988). Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 9: 272–274.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1990

Authors and Affiliations

  • G. Siegel
  • J. Grote

There are no affiliations available

Personalised recommendations